Permira funds to acquire European CNS specialty pharmaceutical company Neuraxpharm
A company backed by global private equity firm Permira, has agreed to acquire Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS) from funds advised by Apax Partners. Financial details of the transaction have not been disclosed. With its unique understanding of the